» Articles » PMID: 15211435

Asymptomatic Cerebral Lacunae in Patients with Chronic Kidney Disease

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 2004 Jun 24
PMID 15211435
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It remains unknown whether the prevalence of silent lacunar infarcts increases as renal function declines or what factors known as atherosclerotic risk factors are related to the development of lacunar infarcts.

Methods: Fifty-one patients with chronic kidney disease without diabetes mellitus and 80 patients with essential hypertension with normal renal function were included in the study. The existence of lacunar infarcts was evaluated on brain magnetic resonance imaging scans. We evaluated the severity of carotid atherosclerosis by means of intima-media thickness of 1.0 mm or greater height in bilateral carotid arteries and by affecting factors, including plasma homocysteine levels.

Results: Lacunae prevalence was 25% in patients with a creatinine clearance (Ccr) greater than 40 mL/min/1.73 m2, 85% in patients with a Ccr less than 40 mL/min/1.73 m2, and 29% in patients with essential hypertension with normal renal function. Patients with lacunae had significantly lower hematocrits associated with increased fibrinogen and lipoprotein(a) levels compared with those without lacunae. Plasma total homocysteine and insulin levels at 2 hours after a 75-g glucose tolerance test correlated significantly with lacunae. Ischemic heart changes shown by electrocardiogram and thickened carotid intima-media thickness were significantly more frequent in patients with lacunae. However, logistic regression analysis showed that the most strongly contributing factor for lacunar infarcts was decline in Ccr (confidence interval, 0.933 to 0.995; P < 0.05).

Conclusion: Decreased renal function, even without diabetes mellitus, is a risk factor for silent lacunar infarcts.

Citing Articles

Cerebral blood flow following successful living kidney transplantation: the VINTAGE study.

Kobayashi S, Hidaka S, Tanabe K Clin Kidney J. 2025; 18(1):sfae392.

PMID: 39877207 PMC: 11773360. DOI: 10.1093/ckj/sfae392.


Intensive Blood Pressure Treatment and Subclinical Brain Infarcts: A Secondary Analysis of SPRINT (Systolic Pressure Intervention Trial).

Kern K, Nasrallah I, Bryan R, Williamson J, Reboussin D, Pajewski N Ann Neurol. 2024; 95(5):866-875.

PMID: 38362733 PMC: 11060925. DOI: 10.1002/ana.26892.


Transcranial Doppler Echography Measurement in Hemodialysis Patients: The Potential Role of Angiotensin II Receptor Blockades on Cerebrovascular Circulation.

Maesato K, Kobayashi S, Ohtake T, Mochida Y, Ishioka K, Oka M J Clin Med. 2023; 12(6).

PMID: 36983296 PMC: 10058379. DOI: 10.3390/jcm12062295.


Relationship between Lower Extremity Peripheral Arterial Disease and Mild Cognitive Impairment in Hemodialysis Patients.

Nishimura A, Hidaka S, Kawaguchi T, Watanabe A, Mochida Y, Ishioka K J Clin Med. 2023; 12(6).

PMID: 36983147 PMC: 10058216. DOI: 10.3390/jcm12062145.


Impact of Arterial Calcification of the Lower Limbs on Long-Term Clinical Outcomes in Patients on Hemodialysis.

Ohtake T, Mitomo A, Yamano M, Shimizu T, Mochida Y, Ishioka K J Clin Med. 2023; 12(4).

PMID: 36835836 PMC: 9967859. DOI: 10.3390/jcm12041299.